Related Experiment Videos
Similarities in bioanalogous structural transformation patterns among various bioactive compound series
1EMIL PROJECT, Fujitsu Kansai Systems Laboratory, Osaka, Japan.
Bioscience, Biotechnology, and Biochemistry
|April 1, 1996
Summary
Bioanalogous structural transformations replace substructures with varied components, expanding beyond bioisosteric replacements. This approach aids in predicting novel bioactive compound structures across diverse therapeutic areas.
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Bioorganic Chemistry
Background:
- Bioisosteric replacement is a common strategy in drug design.
- Structural modifications aim to optimize compound properties.
- Understanding alternative transformation patterns is crucial for innovation.
Purpose of the Study:
- To introduce and define the concept of "bioanalogous" structural transformations.
- To explore precedents of bioanalogous replacements in various bioactive compounds.
- To demonstrate the potential of bioanalogy in predicting new chemical entities.
Main Methods:
- Review and analysis of existing literature on structural transformations of bioactive compounds.
- Identification and categorization of bioanalogous substructure replacements.
- Comparison of transformation patterns across different pharmacological classes.
Main Results:
- Bioanalogous replacements were identified in herbicides, topical antiseptics, local anesthetics, histamine H2-receptor antagonists, agrochemicals, antiandrogens, and CNS-active agents.
- Examples include amide, urea, ester, ether, (thio)urea, cyanoguanidine, and nitroethenediamine substructures.
- Similar substructural transformation patterns were observed across diverse bioanalogous series.
Conclusions:
- Bioanalogous replacement offers a broader scope than bioisosterism for structural modification.
- This strategy can be applied across various therapeutic and chemical classes.
- The observed patterns can guide the design of next-generation bioactive compounds from lead structures.